Business Description
Redhill Biopharma Ltd
NAICS : 325412
ISIN : US7574681034
Share Class Description:
STU:2RH0: ADRDescription
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.75 | |||||
| Equity-to-Asset | 0.09 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 0.21 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -9.58 | |||||
| Beneish M-Score | 1.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -75.7 | |||||
| 3-Year EPS without NRI Growth Rate | 72.1 | |||||
| 3-Year FCF Growth Rate | 63.3 | |||||
| 3-Year Book Growth Rate | -80.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.91 | |||||
| 9-Day RSI | 43.93 | |||||
| 14-Day RSI | 42.34 | |||||
| 6-1 Month Momentum % | 2.67 | |||||
| 12-1 Month Momentum % | -83.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.84 | |||||
| Quick Ratio | 0.61 | |||||
| Cash Ratio | 0.29 | |||||
| Days Inventory | 116.79 | |||||
| Days Sales Outstanding | 119.65 | |||||
| Days Payable | 66.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -173.7 | |||||
| Shareholder Yield % | 111.9 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.74 | |||||
| Operating Margin % | 21.31 | |||||
| Net Margin % | 32.37 | |||||
| FCF Margin % | -71.44 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 16.78 | |||||
| ROIC % | 8.96 | |||||
| ROC (Joel Greenblatt) % | 1095.96 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 1.11 | |||||
| PS Ratio | 0.02 | |||||
| PB Ratio | 4.08 | |||||
| EV-to-EBIT | 0.2 | |||||
| EV-to-EBITDA | 0.08 | |||||
| EV-to-Forward-EBITDA | -3.75 | |||||
| EV-to-Revenue | 0.26 | |||||
| EV-to-Forward-Revenue | 1.37 | |||||
| EV-to-FCF | -0.35 | |||||
| Earnings Yield (Greenblatt) % | 500 | |||||
| FCF Yield % | -192.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Redhill Biopharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 34.828 | ||
| EPS (TTM) (€) | -5.382 | ||
| Beta | 6.33 | ||
| Volatility % | 383.57 | ||
| 14-Day RSI | 42.34 | ||
| 14-Day ATR (€) | 0.02908 | ||
| 20-Day SMA (€) | 0.41725 | ||
| 12-1 Month Momentum % | -83.73 | ||
| 52-Week Range (€) | 0.268 - 3.6 | ||
| Shares Outstanding (Mil) | 31.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Redhill Biopharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Redhill Biopharma Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Redhill Biopharma Ltd Frequently Asked Questions
What is Redhill Biopharma Ltd(STU:2RH0)'s stock price today?
The current price of STU:2RH0 is €0.39. The 52 week high of STU:2RH0 is €3.60 and 52 week low is €0.27.
When is next earnings date of Redhill Biopharma Ltd(STU:2RH0)?
The next earnings date of Redhill Biopharma Ltd(STU:2RH0) is 2024-06-12 Est..
Does Redhill Biopharma Ltd(STU:2RH0) pay dividends? If so, how much?
Redhill Biopharma Ltd(STU:2RH0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers